Neogen Corporation (NEOG)

From the record

Neogen Corporation's filings since 2017 show 2 warning events: a late-report notice (Form NT 10-K or NT 10-Q, 2 times, the latest 2025-01-10) (its current reports).

From the record

Neogen Corporation's 10 filed years say what it did: revenue went from $358 million in fiscal 2017 to $870 million in fiscal 2026, up 10.4% a year; it rose in 7 of 9 years; the deepest fall was 6% from fiscal 2024 to fiscal 2026; net income was positive in 6 of 10 of those years (its annual reports).

From the record

Over the 3 fiscal years to 2026-05-31, Neogen Corporation's diluted share count grew about 4.8% a year, and dividends and buybacks returned about 0% of its operating cash flow over 3 years (its filed statements). Its officers and directors filed 1 sale and 6 purchases of their own stock on the open market in the year to 2026-11-04, buying about $12 thousand (their Form 4 filings).

From the record

Return on equity: in the fiscal year ended 2026-05-31, Neogen Corporation lost about 0 cents for every dollar of shareholders' money, and gross profitability: its products earned about 12 cents per dollar of everything the company owns. Leverage: it owed about 37 cents per dollar of assets, and net share issuance: its share count grew 0.3% over the year (the filed statements).

From the record

Neogen Corporation's standing among 17 graded names in its industry family: revenue of $870 million in fiscal 2026 ranks in the top 21% by size; a net margin of -0.9% ranks in the top 21%; revenue growth of 1.9% a year over the last 3 filed years ranks in the bottom 47% (its annual reports).

From the record

Neogen Corporation's leadership, from its insiders' filings and its current reports: the chief executive on the record is Nassif, Mikheal (CEO, as filed), filing under that title since 2025-08-19, 1.2 years (bottom 29% of its family); the 23 officers and directors filing in the last fifteen months have been on the record a median of 3.9 years (bottom 32%); 16 officer or director changes were reported on Form 8-K since 2023-11-13, against the 23 people in charge now (bottom 23%; fewer changes for each person reads higher) (the Form 4 record, its Form 8-K reports). Years count from a person's first filing in the SEC's data sets, which begin in 2006, so each is a floor.

From the record

Neogen Corporation's room to grow, from the newest filed statements (fiscal 2026): cash of $186 million against debt of $794 million leaves -18.2% of its assets as net cash, bottom 14% of its family; cash from operations less capital spending is 3.7% of revenue (top 22%); a gross margin of 46.9% (bottom 46%); research spending of 2.1% of revenue (bottom 3%) (its annual report).

From the record

Neogen Corporation's growth drivers, from the filed years to fiscal 2026: revenue grew 1.9% a year over the last three filed years against 10.4% over all 10, slowing (bottom 10% of its family); the newest year grew -2.7% (bottom 32%); research spending grew -10.9% a year (bottom 38%); capital spending grew -7.9% a year (top 37%) (its annual reports). Neogen Corporation reported 2 lines of business in fiscal 2026: Food Safety at $641 million (74%), Animal Safety at $229 million (26%); 1 of 2 grew against the year before (its annual report).

From the record

Neogen Corporation's newest year against its own record: revenue of $870 million in fiscal 2026 came in 6.7% below the $933 million its prior three years' pace pointed to (top 50% of its family); net income of $8 million against a prior three-year average of $375 million (top 3%); a net margin of -0.9% against -41.9% before (top 34%) (its annual reports).